Charming Medical Limited faces class action lawsuit
Analysis based on 7 articles · First reported Feb 02, 2026 · Last updated Feb 17, 2026
The market is negatively impacted by the alleged fraudulent activities of Charming Medical Limited, leading to a class action lawsuit and suspension of its shares by the United States===United States Securities and Exchange Commission. This event highlights regulatory scrutiny and potential risks for investors in companies involved in share price manipulation.
DJS Law Group has initiated a class action lawsuit against Charming Medical Limited (NASDAQ: MCTA) for violations of the Securities Exchange Act of 1934. The lawsuit alleges that Charming Medical Limited made false and misleading statements and was involved in a scheme to artificially boost its share price through social media touting by supposed financial advisors. The United States===United States Securities and Exchange Commission has suspended trading of Charming Medical Limited shares pending an investigation into these allegations. Investors who purchased shares during the class period are encouraged to contact DJS Law Group regarding potential lead plaintiff appointments.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard